Bretylium
Other
IV Dose | 5-10 mg by rapid push for VF resistant to DC cardioversion. Dilute in D5W and infuse over 10-20 minutes for treatment of other arrhythmias, to avoid hypotension. May repeat once after 1/2 to 2 hours. Drip 15-30 ug/kg/min or 5-10 mg/kg q 6 hours. Maximum 30 mg/kg/day. |
Oral dose | No oral form |
Levels | Therapeutic range undefined |
Kinetics | Actions delayed up to 1 hour after IV dose, because of slow accumulation in myocardium. Elimination half-life 6.3-13.6 hours. Half-life greatly increased in renal failure. |
Cautions | Hypotension, particularly with rapid IV bolus. |
Interactions | Additive AVN blocking effect with quinidine. Antagonizes local anaesthetic effect of quinidine. Worsens digoxin toxic arrhythmias, via release of norepinephrine. Effects are blocked by tricyclic antidepressants. |
Preparations | Bretylol injection: 500 mg/10 ml ampules, vials. |
FDA approval in children | no (although they gave it to E.T.) |